My name is Jennifer Jackson and I am the Director of Translational Science and Strategy at Personal Genome Diagnostics/Labcorp Oncology. I received my Ph.D. in Biochemistry and Molecular Biology from Emory University and trained in the Department of Surgery at Boston University Medical Center during my postdoctoral fellowship where I focused on assessing the clinical utility of ctDNA as a biomarker for early cancer detection and monitoring of minimal residual disease in response to therapy using dPCR and next-generation sequencing (NGS). Since 2017, I have translated my expertise in precision oncology and technologies to PGDx and Labcorp to support the goals of driving clinical expansion and uptake of NGS through building industry partnerships and collaborations. I have 18 years of oncology-focused research, translational, and clinical experience and 11 years in oncology genomics, biotechnology/diagnostics and have focused my efforts on collaborating with industry professionals and clinicians, commercial and marketing operations, medical affairs, and real-world evidence generation and interpretation in the translational and clinical oncology settings.